Dr. Rupert Patel, MD
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical School at San Antonio (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 112
Licensed in Texas since 2003, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: University of Texas Medical School at San Antonio
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
TX license L5868 (first issued 2003; active) -
Internal Medicine Physician
TX license L5868 (first issued 2003; active) -
Pediatric Nephrology Physician
TX license L5868 (first issued 2003; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hermann Hospital System Houston, TX
- Houston Methodist Sugarland Hospital Sugar Land, TX
- HCA Houston Healthcare West Houston, TX
- St Luke's Sugar Land Hospital Sugar Land, TX
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 112
- Services billed
- 1,076
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Dialysis services, per day, less than full month service (20 years or older) | 628 | 16 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 269 | 61 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 142 | 27 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 101 | 25 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 82 | 24 |
| Established patient office or other outpatient visit, 30-39 minutes | 74 | 46 |
| Established patient office or other outpatient visit, 20-29 minutes | 62 | 35 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 44 | 39 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 30 | 21 |
| Dialysis services, 1 physician visit per month (20 years or older) | 23 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Kerendia (finerenone) Other prescribers in Sugar Land, TX | 73 |
| Sevelamer Carbonate Other prescribers in Sugar Land, TX | 64 |
| Velphoro (sucroferric oxyhydroxide) | 39 |
| Lokelma (sodium zirconium cyclosilicate) Other prescribers in Sugar Land, TX | 29 |
| Nifedipine Er (nifedipine) Other prescribers in Sugar Land, TX | 25 |
| Febuxostat Other prescribers in Sugar Land, TX | 21 |
| Amlodipine Besylate Other prescribers in Sugar Land, TX | 19 |
| Auryxia (ferric citrate) | 19 |
| Jardiance (empagliflozin) Other prescribers in Sugar Land, TX | 19 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Sugar Land, TX | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 31 payments worth $1,148 in total to this clinician.
| Akebia Therapeutics Inc | $282 |
|---|---|
| Novartis Pharmaceuticals Corporation | $156 |
| Nxstage Medical, Inc. | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $114 |
| Lilly USA, LLC | $90.80 |
| Ardelyx, Inc. | $80.91 |
| Mallinckrodt Hospital Products Inc. | $65.04 |
| Fresenius USA Marketing, Inc. | $60.00 |
| Food and Beverage | $1,148 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.